New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
08:18 EDTSGMOSangamo price target raised to $27 from $22 at Wedbush
Wedbush raised its price target for Sangamo BioSciences to $27 saying the phase 1 results published in the New England Journal of Medicine suggest that the company's ZFN approach to treating HIV has broad acceptance in the medical and scientific communities. The firm reiterats an Outperform rating on the stock.
News For SGMO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
10:00 EDTSGMOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:18 EDTSGMOSangamo initiated with an Outperform at BMO Capital
Subscribe for More Information
April 22, 2015
16:10 EDTSGMOSangamo sees FY15 revenue $60M-$70M, consensus $67.71M
16:09 EDTSGMOSangamo reports Q1 EPS (8c), consensus (14c)
Reports Q1 revenue $13.5M, consensus $12.5M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use